Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptamer Group Regulatory News (APTA)

Share Price Information for Aptamer Group (APTA)

Share Price is delayed by 15 minutes
Get Live Data
0.525    0.00 (0.00%)
Bid:
0.50
Ask:
0.55
Spread: 0.05 (10.00%)
Market Cap: £18.14m
APTA Live PriceLast checked at - London Stock Exchange

Intraday Aptamer Group Share Chart

TR-1

15 Aug 2023 17:40

RNS Number : 4198J
Aptamer Group PLC
15 August 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BNRRP542

Issuer Name

APTAMER GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting rights

3. Details of person subject to the notification obligation

Name

Amati Global Investors Limited

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Amati AIM VCT plc

London

United Kingdom

5. Date on which the threshold was crossed or reached

04-Aug-2023

6. Date on which Issuer notified

08-Aug-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.950000

0.000000

3.950000

3138042

Position of previous notification (if applicable)

4.550000

0.000000

4.550000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BNRRP542

3138042

3.950000

Sub Total 8.A

3138042

3.950000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

08-Aug-2023

13. Place Of Completion

Edinburgh, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLNKPBNABKDOFD
Date   Source Headline
30th May 20257:00 amRNSUnilever second Optimer development programme
15th May 20257:01 amRNSAptamer Announces New Data at ASGCT
15th May 20257:00 amRNSOptimer licensing agreements and repeat contracts
6th May 20257:00 amRNSAlzheimer’s test advanced and royalty agreement
30th Apr 20257:00 amRNSLicensing agreed for Optimer as vaccine adjuvant
29th Apr 20257:00 amRNS-RAptamer Presenting at ASGCT Annual Meeting
24th Apr 20257:00 amRNS-RNew Corporate Presentation and Investor Factsheet
11th Mar 20257:00 amRNSInterim Results
27th Feb 202512:50 pmRNSTR-1: Standard form notification of major holdings
25th Feb 20257:01 amRNSBlock Listing Interim Review
25th Feb 20257:00 amRNSNotice of Results and Investor Presentation
28th Jan 20252:56 pmRNSIssue of Equity in lieu of Director fees
28th Jan 20257:00 amRNSHalf Year Trading Update
13th Jan 202511:40 amRNSNotification of dealings by a director/PDMR
30th Dec 20247:00 amRNSHolding(s) in Company
19th Dec 20244:44 pmRNSNotification of dealings by a director/PDMR
19th Dec 20247:00 amRNSNew Development Contract
18th Dec 202410:53 amRNSTR-1: Standard form notification of major holdings
16th Dec 202411:28 amRNSNotification of dealings by a director/PDMR
12th Dec 20247:00 amRNSHolding(s) in Company
9th Dec 20243:30 pmRNSNotification of dealings by a director/PDMR
9th Dec 20241:47 pmRNSNotification of dealings by a director/PDMR
9th Dec 20247:00 amRNSGrant of Options and Director Fee Shares
6th Dec 20247:00 amRNSNew Scientific Advisory Board Members
5th Dec 20247:00 amRNSTechnical Update
4th Dec 20247:00 amRNS-RInvestor Webinar
29th Nov 202411:05 amRNSResults of 2024 Annual General Meeting
29th Nov 20247:00 amRNSAGM Statement
7th Nov 20247:00 amRNSAgreement extended with genetic medicines customer
6th Nov 20247:00 amRNSCommercial Trading Update
5th Nov 20247:00 amRNSPosting of Annual Report and Notice of AGM
22nd Oct 20247:00 amRNSFull Year Results for the 12mths to 30 June 2024
17th Oct 20247:00 amRNSNotice of Results and Investor Presentation
16th Sep 20247:00 amRNSDirector Appointment
3rd Sep 20247:00 amRNSAptamer extends contract with Unilever
27th Aug 20247:00 amRNSBlock listing Interim Review
20th Aug 20242:26 pmRNSHolding(s) in Company
16th Aug 20241:04 pmRNSTR-1: Standard form notification of major holdings
14th Aug 202411:34 amRNSTR-1: Standard form notification of major holdings
13th Aug 202412:57 pmRNSResult of General Meeting and Board Changes
1st Aug 20244:33 pmRNSSupplementary Conditional Placing for £60,000
24th Jul 20246:11 pmRNSPosting of Circular and Notice of General Meeting
24th Jul 202412:37 pmRNSFundraise to Raise £2.83 million
8th Jul 20247:05 amRNSUpdate on progress in Unilever partnership
8th Jul 20247:00 amRNSTrading Update
3rd Jul 20247:00 amRNSAgreement to explore Optimer vehicles for siRNA
24th Jun 20247:00 amRNSNew Contracts Announcement for Optimer Development
14th Jun 20247:00 amRNSPartnership with Microsaic Systems
31st May 20244:06 pmRNSHolding(s) in Company
28th May 20249:05 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.